Legionella pneumonia: Assessing the latest diagnostic tests

Journal of Respiratory Diseases

Volumn 25, Issue 10, 2004, Pages 404-418

  Morrison, April R ^a   Gupta, Samir K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL ANTIGEN; BETA LACTAM ANTIBIOTIC; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFAPENTINE; TETRACYCLINE;

ANTIBIOTIC THERAPY; BACTERIAL GROWTH; CLINICAL FEATURE; COMMUNICABLE DISEASE; CULTURE MEDIUM; DIAGNOSTIC KIT; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; EVALUATION; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LEGIONELLA; NONHUMAN; PNEUMONIA; REVIEW; URINALYSIS;

EID: 6044252334     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Gupta SK, Sarosi GA. The role of atypical pathogens in community-acquired pneumonia. Med Clin North Am. 2001;85:1349-1365.
2. Summary of notifiable diseases, United States, 2001. Available at: http://www.cdc.gov/mmwr/summary.html. Accessed July 19, 2004.
3. Gupta SK, Imperiale TF, Sarosi GA. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest. 2001;120:1064-1071.
4. Fernandez-Sabe N, Roson B, Carratala J, et al. Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. Clin Infect Dis. 2003;37:483-489.
5. Bartlett JG, Dowell SF, Mandell LA et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347-382.
6. Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis. 1996;15:286-290.
7. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730-1754.
8. Cunha BA. Clinical features of legionnaires' disease. Semin Respir Infect. 1998;13:116-127.
9. Keller DW, Lipman HB, Marston BJ, et al. Clinical diagnosis of Legionnaires' disease using a multivariate model. In: Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17-20, 1995. San Francisco: American Society for Microbiology; 1995.
10. Mulazimoglu L, YU VL. Can Legionnaires disease be diagnosed by clinical criteria? A critical review. Chest. 2001;120:1049-1053.
11. Murdoch DR. Diagnosis of Legionella infection. Clin Infect Dis. 2003;36:64-69.
12. Lee TC, Vickers RM, Yu VL, Wagener MM. Growth of 28 Legionella species on selective culture media: a comparative study. J Clin Microbiol. 1993;31:2764-2768.
13. Marston BJ, Lipman HB, Breiman RF. Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med. 1994;154:2417-2422.
14. Stout JE, Yu VL. Legionellosis. N Engl J Med. 1997;337:682-687.
15. Kohler RB, Zimmerman SE, Wilson E, et al. Rapid radioimmunoassay diagnosis of Legionnaires' disease: detection and partial characterization of urinary antigen. Ann Intern Med. 1981;94:601-605.
16. Kohler RB, Winn WC Jr, Wheat LJ. Onset and duration of urinary antigen excretion in Legionnaires disease. J Clin Microbiol. 1984;20:605-607.
17. Dominguez JA, Gali N, Pedroso P, et al. Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urine antigen EIA for detection of Legionella antigen in both concentrated and non-concentrated urine samples. J Clin Microbiol. 1998;36:2718-2722.
18. Harrison TG, Doshi N. Evaluation of the Bartels Legionella Urinary Antigen enzyme immunoassay. Eur J Clin Microbiol Infect Dis. 2001;20:738-740.
19. Wever PC, Yzerman EP, Kuijper EJ, et al. Rapid diagnosis of Legionnaires' disease using an immunochromatographic assay for Legionella pneumophila serogroup 1 antigen in urine during an outbreak in the Netherlands. J Clin Microbiol. 2000;38:2738-2739.
20. Benson RF, Tang PW, Fields BS. Evaluation of the Binax and Biotest urinary antigen kits for detection of Legionnaires' disease due to multiple serogroups and species of Legionella. J Clin Microbiol. 2000;38:2763-2765.
21. Helbig JH, Uldum SA, Bernander S, et al. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease. J Clin Microbiol. 2003;41:838-840.
22. Benin AL, Benson RF, Besser RE. Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin Infect Dis. 2002;35:1039-1046.
23. Murdoch DR. Nucleic acid amplification tests for the diagnosis of pneumonia. Clin Infect Dis. 2003;36:1162-1170.
24. Helbig JH, Engelstadter T, Maiwald M, et al. Diagnostic relevance of the detection of Legionella DNA in urine samples by the polymerase chain reaction. Eur J Clin Microbiol infect Dis. 1999;18:716-722.
25. Aoki S, Hirakata Y, Miyazaki Y, et al. Detection of Legionella DNA by PCR of whole-blood samples in a mouse model. J Med Microbiol. 2003;52:325-329.
26. Raggam RB, Leitner E, Muhlbauer G, et al. Qualitative detection of Legionella species in bronchoalveolar lavages and induced sputa by automated DNA extraction and real-time polymerase chain reaction. Med Microbiol Immunol (Berl). 2002;191:119-125.
27. Welti M, Jaton K, Altwegg M, et al. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis. 2003;45:85-95.
28. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003;37:1405-1433.
29. Roig J, Rello J. Legionnaires' disease: a rational approach to therapy. J Antimicrob Chemother. 2003;51:1119-1129.
30. Schulin T, Wennersten CB, Ferraro MJ, et al. Susceptibilities of Legionella spp. to newer antimicrobials in vitro. Antimicrob Agents Chemother. 1998;42:1520-1523.
31. Baltch AL, Smith RP, Franke MA, Michelsen PB. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila. Antimicrob Agents Chemother. 1998;42:3153-3156.